Potential role of FDG PET/CT imaging for assessing venous thromboembolic disorders

Clinical Nuclear Medicine

Volumn 37, Issue 12, 2012, Pages 1170-1172

  Hess, Søren ^a   Madsen, Poul Henning ^a   Basu, Sandip ^b,c   Høilund Carlsen, Poul Flemming ^a   Alavi, Abass ^c  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b TATA MEMORIAL HOSPITAL   (India)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

deep venous thrombosis; molecular imaging; PET CT; pulmonary embolism; venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; FLUORODEOXYGLUCOSE F 18;

ANTICOAGULANT THERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DEEP VEIN THROMBOSIS; HUMAN; LEG THROMBOSIS; LUNG EMBOLISM; NOTE; SENSITIVITY AND SPECIFICITY; VENOUS THROMBOEMBOLISM;

ANIMALS; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; VENOUS THROMBOEMBOLISM;

EID: 84870213171     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318279bf73     Document Type: Note

References (40)

1. Rondina MT, Lam UK, Pendleton RC, et al. F-18 Fluorodeoxyglucose positron emission tomography in the evaluation of acuity of deep vein thrombosis. Clin Nucl Med. 2012; In press.
2. Kroegel C, Reissig A. Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis. Respiration. 2003;70:7-30.
3. Kearon C. Natural history of venous thromboembolism. Circulation. 2003;107: I22YI30.
4. Douma RA, Kamphuisen PW, Büller HR. Acute pulmonary embolism. Part 1: epidemiology and diagnosis. Nat Rev Cardiol. 2010;7:585-596.
5. American Thoracic Society. The diagnostic approach to acute venous thromboembolism. Am J Respir Crit Care Med. 1999;160:1043-1066.
6. Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2008;29:2276-2315.
7. Goodman LR, Stein PD, Matta F, et al. CT venography and compression sonography are diagnostically equivalent: data from PIOPED II. AJR Am J Roentgenol. 2007;189:1071-1076.
8. Nazaroglu H, Ozmen CA, Akay HO, et al. 64-MDCT pulmonary angiography and CT venography in the diagnosis of thromboembolic disease. AJR Am J Roentgenol. 2009;192:654-661.
9. Schellong SM, Beyer J, Kakkar AK, et al. Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study. J Thromb Haemost. 2007;5:1431-1437.
10. Turkstra F, Kuijer PM, van Beek EJ, et al. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med. 1997;126:775-781.
11. Wells PS, Ginsberg JS, Anderson DR, et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med. 1998;129:997-1005.
12. Byrne JJ, O'Neil EE. Fatal pulmonary emboli: a study of 130 autopsy proven fatal emboli. Am J Surg. 1952;83:47-49.
13. Cohn R, Walsh J. The incidence and anatomical site of origin of pulmonary emboli. Stanford Med Bull. 1946;4:97-99.
14. Sevitt S, Gallagher N. Venous thrombosis and pulmonary embolism. A clinicopathological study in injured and burned patients. Br J Surg. 1961;48:475-489.
15. Short DS. A survey of pulmonary embolism in a general hospital. Br Med J. 1952;1:790-796.
16. Hess S, Madsen PH, Jørgensen HB, et al. Diagnostic imaging in acute pulmonary embolism. The use of spiral computed tomography, lung scintigraphy and echocardiography [in Danish]. Ugeskr Laeger. 2005;167:3870-3875.
17. Gutte H, Mortensen J, Jensen CV, et al. Detection of pulmonary embolism with combined ventilation-perfusion SPECT and low-dose CT: head-to-head comparison with multidetector CT angiography. J Nucl Med. 2009;50:1987-1992.
18. Stein PD, Woodard PK, Weg JG, et al. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators. Radiology. 2007;242:15-21.
19. Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006;354:2317-2327.
20. Basu S, Alavi A. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades. J Nucl Med. 2008;49:17NY21N, 37N.
21. El-Haddad G, Zhuang H, Gupta N, et al. Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med. 2004;34:313-329.
22. Basu S, Zhuang H, Torigian DA, et al. Functional imaging in inflammatory diseases using nuclear medicine techniques. Semin Nucl Med. 2009;39:124-145.
23. Chang KJ, Zhuang H, Alavi A. Detection of chronic recurrent lower extremity deep venous thrombosis on fluorine-18 fluorodeoxyglucose positron emission tomography. Clin Nucl Med. 2000;25:838-839.
24. Bhargava P, Kumar R, Zhuang H, et al. Catheter-related focal FDG activity on whole body PET imaging. Clin Nucl Med. 2004;29:238-242.
25. Sydow BD, Srinivas SM, Newberg A, et al. Deep venous thrombosis on F-18 PET/CT imaging. Clin Nucl Med. 2006;31:403-404.
26. Cañete-Sánchez FM, Gandhi M, Evans TL, et al. Detection by 18F-FDG-PET/CT of upper extremity acute deep venous thrombosis. Hell J Nucl Med. 2011; 14:81-82.
27. Probst S, Seltzer A, Chachoua A, et al. Azygos venous tumor thrombus from renal cell carcinoma detected by 18F-FDG PET/CT. Clin Nucl Med. 2010; 35:832-833.
28. Sun L, Guan YS, Pan WM, et al. Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma. World J Gastroenterol. 2008;14:1212-1217.
29. Davidson T, Goitein O, Avigdor A, et al. 18F-FDG-PET/CT for the diagnosis of tumor thrombosis. Isr Med Assoc J. 2009;11:69-73.
30. Farsad M, Pernter P, Triani A, et al. Thromboembolism in pulmonary artery sarcoma. Clin Nucl Med. 2009;34:239-240.
31. Tueller C, Fischer Biner R, Minder S, et al. FDG-PET in diagnostic work-up of pulmonary artery sarcomas. Eur Respir J. 2010;35:444-446.
32. Agrawal A, Agrawal R, Asopa R, et al. Detection of superior sagittal sinus thrombosis on FDG PET. Clin Nucl Med. 2009;34:161-163.
33. Tripathi M, D'Souza M, Jain J, et al. Sagittal sinus tumor thrombosis in a case of NHL demonstrated on 18F-FDG PET/CT. Clin Nucl Med. 2011;36:252-254.
34. Wakefield TW, Strietert RM, Princet MR, et al. Pathogenesis of venous thrombosis: a new insight. Cardiovasc Surg. 1997;5:6-15.
35. Line BR. Pathophysiology and diagnosis of deep venous thrombosis. Semin Nucl Med. 2001;31:90-101.
36. Khosa F, Otero HJ, Prevedello LM, et al. Imaging presentation of venous thrombosis in patients with cancer. AJR Am J Roentgenol. 2010;194:1099-1108.
37. Baglin T. What happens after venous thromboembolism? J Thromb Haemost. 2009;7(suppl. 1):287-290.
38. Rodrigues CA, Ferrarotto R, Filho RK, et al. Venous thromboembolism and cancer: a systematic review. J Thromb Thrombolysis. 2010;30:67-78.
39. Murano T, Minamimoto R, Senda M, et al. Radiation exposure and risk-benefit analysis in cancer screening using FDG-PET: results of a Japanese nationwide survey. Ann Nucl Med. 2011;25:657-666.
40. Mattsson S, Söderberg M. Radiation dose management in CT, SPECT/CT, and PET/CT techniques. Radiat Prot Dosimetry. 2011;147:13-21.